ORCID as entered in ROS

Select Publications
2019, 'Unintended Consequences of a National Policy Intervention to Curb Inappropriate Alprazolam Prescribing in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 34 - 35, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000481785600063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'CHARACTERISING PEOPLE ATTENDING NEW SOUTH WALES EMERGENCY DEPARTMENTS AND HOSPITALS FOR AN ALCOHOL-RELATED PROBLEM, 2005-2014: THE DATA-LINKAGE ALCOHOL COHORT STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S81 - S82
,2018, 'Using Australia’s National Data Linkage Demonstration Project (NDLDP) to improve cardiac care: Towards a national, whole-of-population linked data resource for evidence-informed health policy', in International Journal of Population Data Science, Swansea University, Banff, Canada, Vol. 3, presented at International Population Data Linkage Conference 2018, Banff, Canada, http://dx.doi.org/10.23889/ijpds.v3i4.640
,2018, 'The safety of fentanyl patch initiation in Australian clinical practice: A population-based study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 27, pp. 437 - 437, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000441893804049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'PATTERNS OF PRESCRIBED ASTHMA MEDICINE USE IN AUSTRALIAN CHILDREN: A POPULATION-BASED STUDY', in RESPIROLOGY, WILEY, Vol. 23, pp. 107 - 107, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427591800192&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'P2Y12 Inhibitor Therapy is Underutilised in Patients Hospitalised for Acute Myocardial Infarction: Results From a New Population-Level Data Linkage in Australia', in Heart, Lung and Circulation, Elsevier, Brisbane, Australia, Vol. 27, pp. s333, presented at Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Brisbane, Australia, http://dx.doi.org/10.1016/j.hlc.2018.06.647
,2018, 'Use of Oral Anticoagulants After Hospital Discharge in Patients With Atrial Fibrillation: Insights From a New Population-Level Linkage in Australia', in Heart, Lung and Circulation, Elsevier, Vol. 27, pp. s356, presented at Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, http://dx.doi.org/10.1016/j.hlc.2018.06.701
,2017, 'Two-Year Statin Adherence Trajectories in Initiators of Combined Amlodipine-Atorvastatin Therapy: A Population-Based Study (2005–2015)', in Abstracts of the 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, WILEY, Montreal, Canada, Vol. 26, pp. 519 - 520, presented at International Conference on Pharmacoepidemiology, Montreal, Canada, 27 August 2017 - 30 August 2017, http://dx.doi.org/10.1002/pds.4275
,2016, 'Initiation Of Strong Prescription Opioids In Australia: Cohort Characteristics And Factors Associated With The Type Of Opioid Initiated', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, Vol. 25, pp. 212 - 213, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385483501355&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, Health Care Homes trial final evaluation report, Volume 1: Summary report, https://www.health.gov.au/sites/default/files/documents/2022/08/evaluation-of-the-health-care-homes-trial-final-evaluation-report-2022-summary-report.pdf
,2022, Health Care Homes trial final evaluation report, Volume 3: Methods and data supplement, https://www.health.gov.au/sites/default/files/documents/2022/08/evaluation-of-the-health-care-homes-trial-final-evaluation-report-2022-methods-and-data-supplement.pdf
,2021, Health Care Homes PHN Benchmark Report: July 2020 - December 2020 (Round 5)
,2021, Health Care Homes Practice Benchmark Report: July 2020 - December 2020 (Round 5)
,2021, Evaluation of the Health Care Homes program - Interim evaluation report 2020 Volume 1: Summary report, https://www1.health.gov.au/internet/main/publishing.nsf/Content/Evaluation-of-the-Health-Care-Homes-Program
,2020, Health Care Homes PHN Benchmark Report: January 2020 - June 2020 (Round 4)
,2020, Health Care Homes Practice Benchmark Report: January 2020 - June 2020 (Round 4)
,2020, Evaluation of the Health Care Homes program - Interim evaluation report 2019, Volume 1: Summary report
,2020, Health Care Homes PHN Benchmark Report: June 2019 - December 2019 (Round 3)
,2020, Health Care Homes Practice Benchmark Report: June 2019 - December 2019 (Round 3)
,2019, Evaluation of the Health Care Homes program - Evaluation plan
,2019, Health Care Homes Practice Benchmark Report: February 2018 - June 2019 (Round 2)
,2019, Health Care Homes Primary Health Network (PHN) Benchmark Report: February 2018 - June 2019 (Round 2)
,2019, Health Care Homes Practice Benchmark Report: February 2018 - December 2018 (Round 1)
,2019, Health Care Homes Primary Health Network (PHN) Benchmark Report: February 2018 - December 2018 (Round 1)
,2018, Delivering better cardiac outcomes: Primary, specialist and hospital care
,2017, Post-market Review - Pulmonary Arterial Hypertension Medicines
,2024, The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia, http://dx.doi.org/10.1101/2024.04.29.24306520
,2023, Antipsychotic Use During Pregnancy and Risk of Specific Neurodevelopmental Disorders and Learning Difficulties in Children: A Multinational Cohort Study, http://dx.doi.org/10.2139/ssrn.4652505
,2023, Association between Antihypertensive Medicine Use and Risk of Ovarian Cancer in Women Aged 50 Years and Older, http://dx.doi.org/10.2139/ssrn.4414764
,2023, Effectiveness of COVID-19 Vaccination Against Covid-19 Specific and All-Cause Mortality in Older Australians, http://dx.doi.org/10.2139/ssrn.4445191
,2021, Incidence And Risk Factors of Hypertension Therapy In Australian Cancer Patients Treated With Vascular Signalling Pathway Inhibitors, http://dx.doi.org/10.21203/rs.3.rs-1006781/v1
,2021, Availability, Formulation, Labeling, and Price of Low-sodium Salt Worldwide: Environmental Scan (Preprint), http://dx.doi.org/10.2196/preprints.27423
,2021, Changes in antidepressant use in Australia: A nationwide analysis prior to and during the COVID-19 pandemic (2015-2021), http://dx.doi.org/10.1101/2021.11.24.21266837
,2021, Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia, http://dx.doi.org/10.1101/2021.09.26.21264150
,2020, Variations in Long-Term Opioid Therapy Definitions: A Systematic Review of Observational Studies Using Routinely Collected Data (2000–2019), http://dx.doi.org/10.22541/au.160192979.95446629/v1
,2018, Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: a national population-based observational study (2001-2016), http://dx.doi.org/10.1101/324343
,2024, Data from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.c.7061343
,2024, Data from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.c.7061343.v1
,2024, Supplementary Figure S1 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.25151343
,2024, Supplementary Figure S1 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.25151343.v1
,2024, Supplementary Figure S2 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.25151340
,2024, Supplementary Figure S2 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.25151340.v1
,2024, Supplementary Figure S3 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.25151337.v1
,2024, Supplementary Figure S3 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.25151337
,2024, Supplementary Figure S4 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.25151334.v1
,2024, Supplementary Figure S4 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.25151334
,2024, Supplementary Table S1 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.25151331
,2024, Supplementary Table S1 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.25151331.v1
,2024, Supplementary Table S2 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.25151328.v1
,2024, Supplementary Table S2 from Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016, http://dx.doi.org/10.1158/1055-9965.25151328
,